When Patients Take Control: Prevalence, Motivations, and Clinical Correlates of Self-Initiated Psychiatric Medication Changes [0.03%]
当患者掌握主动权时：自行更改精神病药物的流行率、动机及临床相关性
Amin Mehmedović,Teodora Milojević,Iva Binić et al.
Amin Mehmedović et al.
Purpose: To examine the prevalence and patterns of mental health patients' consideration and engagement in self-initiated psychiatric medication discontinuation, identify their motivations, and assess associated factors i...
AI Aversion: Do People Trust and Accept Artificial Intelligence Risk Calculator Recommendations? [0.03%]
人们对人工智能风险计算器的信赖与接受度研究：人工智能厌恶感的影响作用
Madhuri Ramasubramanian,Brian J Zikmund-Fisher
Madhuri Ramasubramanian
Introduction: Although medical risk calculators are increasingly being used for risk prediction in various contexts, prior research in this area suggests that people may be averse to recommendations from these tools. More...
Effect of Personalized Risk Messages on Patient Intent and Decision Making in Colorectal Cancer Screening: A Randomized Controlled Trial [0.03%]
结直肠癌筛查中个性化风险信息对患者意向和决策影响的随机对照试验
Peter H Schwartz,Thomas F Imperiale,Susan M Perkins et al.
Peter H Schwartz et al.
PurposeTo measure the impact of a personalized message about current risk of having advanced colorectal neoplasia (ACN; colorectal cancer [CRC] or advanced precancerous polyp) on informed concordance and CRC screening decision-making outcom...
Employing Psychological Distance to Explain Perspective-Specific EQ-5D-Y-3L Health State Valuation: A Bayesian Hierarchical Analysis [0.03%]
运用心理距离解释视角特异性EQ-5D-Y-3L健康状态评估：贝叶斯分层分析方法
Zhongyu Lang,Arthur E Attema,Stefan A Lipman
Zhongyu Lang
Background: The EQ-5D-Y-3L is a widely used instrument for valuing health states in pediatric populations. Previous studies have shown that composite time tradeoff (cTTO) utilities tend to be higher when adults value heal...
Comparing and Selecting Network Meta-Analysis Models for Cost-Effectiveness Analysis of Anticancer Drugs [0.03%]
用于抗癌药物成本效益分析的网络 meta 分析模型的比较与选择
Mingye Zhao,Taihang Shao,Hanqiao Shao et al.
Mingye Zhao et al.
Objectives: To systematically evaluate how survival estimates from network meta-analyses (NMA) models affect oncology cost-effectiveness analysis (CEA) results, particularly under different proportional hazards (PH) assum...
Development of a Unified Framework for Evaluating the Quality of Physician Communication in Prostate Cancer Treatment Consultations [0.03%]
前列腺癌治疗咨询中医师沟通质量评估统一框架的构建
Alexander Hernandez-Tirado,Renning Zheng,Michael Luu et al.
Alexander Hernandez-Tirado et al.
Background: Physicians often fail to communicate important details about key risks and benefits of treatment in prostate cancer consultations, an information gap that may inhibit effective patient participation in care de...
A Simulation and Case Study to Evaluate the Extrapolation Performance of Flexible Bayesian Survival Models when Incorporating Real-World Data [0.03%]
一种模拟和案例研究，用于评估在纳入真实世界数据时灵活的贝叶斯生存模型的外推性能
Iain R Timmins,Fatemeh Torabi,Christopher H Jackson et al.
Iain R Timmins et al.
BackgroundAssessment of long-term survival for health technology assessment often necessitates extrapolation beyond the duration of a clinical trial. Flexible Bayesian survival models that incorporate longer-term data sources, including reg...
Integrating Vaginal Microbiome Test Results into Shared Decision Making during In Vitro Fertilization Care [0.03%]
将阴道微生物组检测结果融入体外受精治疗中的共同决策过程
Rivka Koedooder,Xu Shan Gao,Sam Schoenmakers et al.
Rivka Koedooder et al.
Background: The vaginal microbiota test predicts the success of in vitro fertilization (IVF), but with no therapy available to improve a low profile, couples must decide whether to proceed or postpone treatment. We aim to...
Flexible Survival Extrapolation with Blended Hazards: Accounting for Treatment Effect Waning in Health Technology Assessment [0.03%]
一种灵活的生存外推方法：健康技术评估中考虑治疗效果衰减的混合危险模型
Jingqi Zhu,Matthew Hemstock,Zhaojing Che et al.
Jingqi Zhu et al.
BackgroundSurvival extrapolation is crucial in estimating the lifetime survival benefit of a treatment for health technology assessment (HTA). Conventional extrapolation methods, which assume that the long-term treatment effect (hazard rati...
A Microsimulation Model for Chronic Kidney Disease Progression in Type 2 Diabetes Patients in the United States: Michigan Model for Diabetes-Chronic Kidney Disease Model [0.03%]
美国2型糖尿病患者慢性肾脏病发展的微观模拟模型：密歇根糖尿病-慢性肾病模型
Wen Ye,Xuemei Ding,Jing Li et al.
Wen Ye et al.
ObjectivesTo develop and validate a microsimulation model to estimate the health outcomes and costs of chronic kidney disease (CKD) in type 2 diabetes (T2D) to inform health policies and reduce the burden of CKD.MethodsWe developed a compre...